Simplex Trading
GYRE icon

Simplex Trading’s Gyre Therapeutics GYRE Stock Holding History

Simplex Trading’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.7K Sell
674
-165
-20% -$1.28K ﹤0.01% 7932
2025
Q4 		$5.92K Buy
839
+675
+412% +$5.21K ﹤0.01% 7334
2025
Q3 		$1K Buy
+164
New +$1.25K ﹤0.01% 8812
2023
Q2 		– Sell
-2,962
Closed -$10.6K – 9340
2023
Q1 		$9K Buy
+2,962
New +$11.3K ﹤0.01% 7621
2022
Q1 		– Sell
-306
Closed -$1.52K – 10774
2021
Q4 		$2K Buy
+306
New +$5.23K ﹤0.01% 9992
2020
Q3 		– Sell
-4,101
Closed -$161K – 8060
2020
Q2 		$180K Sell
4,101
-670
-14% -$31.5K ﹤0.01% 4110
2020
Q1 		$156K Buy
4,771
+3,968
+494% +$182K ﹤0.01% 3876
2019
Q4 		$41K Sell
803
-8
-1% -$335 ﹤0.01% 5375
2019
Q3 		$29K Sell
811
-1,081
-57% -$58.3K ﹤0.01% 5517
2019
Q2 		$104K Sell
1,892
-1,026
-35% -$64.1K ﹤0.01% 4146
2019
Q1 		$177K Sell
2,918
-798
-21% -$51.3K ﹤0.01% 3739
2018
Q4 		$219K Buy
3,716
+3,150
+557% +$232K ﹤0.01% 3077
2018
Q3 		$45K Sell
566
-5,066
-90% -$401K ﹤0.01% 5265
2018
Q2 		$492K Buy
5,632
+3,952
+235% +$693K ﹤0.01% 2473
2018
Q1 		$325K Buy
+1,680
New +$313K 0.01% 953
2017
Q2 		– Sell
-2,216
Closed -$156K – 6361
2017
Q1 		$156K Buy
+2,216
New +$129K 0.01% 1408
2015
Q3 		– Sell
-1
Closed -$1K – 5758
2015
Q2 		$1K Hold
1
– – ﹤0.01% 4662
2015
Q1 		$1K Buy
+1
New +$2.07K ﹤0.01% 4480

Other funds holding GYRE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Simplex Trading's GYRE Position: Q1 2026 in Review

Simplex Trading reduced its Gyre Therapeutics (GYRE) stake by 20% in Q1 2026, selling an estimated $1.28K and leaving 674 shares worth $4.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7932.

Simplex Trading first reported a position in GYRE in Q1 2015 and has held it in 18 quarters since. The position peaked at $492K in Q2 2018. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

  • Simplex Trading held 674 shares of Gyre Therapeutics worth $4.7K as of Q1 2026.
  • Simplex Trading sold 165 Gyre Therapeutics shares in Q1 2026, an estimated $1.28K.
  • Gyre Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7932 holding.
  • Simplex Trading first reported a position in Gyre Therapeutics in Q1 2015 and has held it in 18 quarters since.
  • Simplex Trading's Gyre Therapeutics position peaked at $492K in Q2 2018.
  • 56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.